Stryker Corporation (SYK)

Market Cap	150.71B
Revenue (ttm)	23.82B
Net Income (ttm)	2.92B
Shares Out	382.31M
EPS (ttm)	7.55
PE Ratio	52.21
Forward PE	27.90
Dividend	$3.36 (0.85%)
Ex-Dividend Date	Sep 30, 2025

Volume	896,076
Open	385.75
Previous Close	384.83
Day's Range	384.33 - 395.23
52-Week Range	329.16 - 406.19
Beta	0.91
Analysts	Buy
Price Target	427.67 (+8.49%)
Earnings Date	Jul 31, 2025

About SYK

Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1941
• Employees: 53,000
• Stock Exchange: NYSE
• Ticker Symbol: SYK
• Website: https://www.stryker.com

Financial Performance

In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.

Analyst Summary

According to 19 analysts, the average rating for SYK stock is "Buy." The 12-month stock price target is $427.67, which is an increase of 8.49% from the latest price.

Price Target

$427.67

(8.49% upside)

Analyst Consensus: Buy